Capability of oxytocin in improving the efficacy of MRI-HIFU is studied. Patients undergoing MRI-HIFU treatment are given oxytocin during treatment and the efficacy of the treatment will be analysed by patient reported symptom questionnaires and imaging data.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
100
Oxytocin infusion during MRI-HIFU treatment
Turku University Hospital
Turku, Finland
NPV
non perfused volume (percentage of fibroid destroyed)
Time frame: up to one year
duration of MRI-HIFU
duration of MRI-HIFU treatment
Time frame: up to one year
UFS-Qol
Uterine fibroid symptom severity and quality of life (patient quality of life questionnaire)
Time frame: 12 months after HIFU treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.